Orchard Therapeutics North America is a biopharmaceutical company based in Massachusetts that develops gene therapies and other advanced treatments. Its filings show it lobbied on Medicare and Medicaid issues, general health policy, and pharmacy-related matters, likely to influence how public programs and pharmacies cover or pay for its therapies. The disclosures list one filing with no reported spending and a hired lobbying firm.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BRETT MEEKS
The latest disclosures for this client.
JEFFREY J. KIMBELL & ASSOCIATES, INC.
Q2JEFFREY J. KIMBELL & ASSOCIATES, INC.
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
JEFFREY J. KIMBELL & ASSOCIATES, INC.
DAVID RUDLOFF
JEFFREY J. KIMBELL & ASSOCIATES, INC.
JOHN HERZOG
JEFFREY J. KIMBELL & ASSOCIATES, INC.
JOHN R RAY
JEFFREY J. KIMBELL & ASSOCIATES, INC.
KEITH STUDDARD
JEFFREY J. KIMBELL & ASSOCIATES, INC.
LAURA KEMPER
JEFFREY J. KIMBELL & ASSOCIATES, INC.
mr JEFFREY J KIMBELL
JEFFREY J. KIMBELL & ASSOCIATES, INC.
mr KENNETH LEE HODGE
JEFFREY J. KIMBELL & ASSOCIATES, INC.
JEFFREY J. KIMBELL & ASSOCIATES, INC.
RR